SCHEMBL4300939

SCHEMBL4300939

COc1cc(=O)n(CC=O)c2cc(F)ccc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CBX7 O95931 1/20 0.37
CDYL2 Q8N8U2 1/20 0.37
CDYL Q9Y232 1/20 0.37
CDY1; CDY1B Q9Y6F8 1/20 0.37
GRIN1 Q05586 3/20 0.35
GRIN2B Q13224 3/20 0.35
RXFP1 Q9HBX9 2/20 0.35
PRNP P04156 1/20 0.35
ATM Q13315 1/20 0.35
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
POLB P06746 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3839427 0.89 KDM4E (0.37) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL3858449 0.88 TNFRSF1A (0.40) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL12000221 0.85 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL2799701 0.83 MAT2A (0.41) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL2795612 0.82 ALDH1A1 (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2RXFP1
SCHEMBL2795647 0.82 ALDH1A1 (0.47) ALDH1A1HPGDKDM4EHSD17B10ATM
SCHEMBL4294279 0.80 PER2 (0.33) PER2CRY1CRY2
SCHEMBL2798863 0.79 KMT2A (0.39) ALDH1A1HPGDSMN1; SMN2ATMMEN1
SCHEMBL3857297 0.77 HCRTR1 (0.38) ALDH1A1HPGDKDM4EGLAGAA
SCHEMBL2800336 0.76 TNFRSF1A (0.43) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8071592-B2 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2011-12-06 US disclosed
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2009-10-29 US disclosed
EP-1992628-A1 Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones GLAXO GROUP LIMITED (GB) 2008-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270374-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES ETFA, NQO2, GNAQ ALDH1A1 3885/4885HPGD 302/4885KDM4E 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.